1,3-Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Expanding Structural Diversity and the Antibacterial Spectrum.
1,3-Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Expanding Structural Diversity and the Antibacterial Spectrum.
复制标题
1,3-二恶烷连接的新型细菌拓扑异构酶抑制剂:扩大结构多样性和抗菌谱。
DOI:
10.1021/acsmedchemlett.2c00111
复制
发表时间:
2022
影响因子:
4.2
通讯作者:
Wozniak,D
中科院分区:
文献类型:
--
作者:
Lu,Yanran;Mann,ChelseaA;Nolan,Sheri;Collins,JessicaA;Parker,Elizabeth;Papa,Jonathan;Vibhute,Sandip;Jahanbakhsh,Seyedehameneh;Thwaites,Mary;Hufnagel,David;Hazbón,ManzourH;Moreno,Jane;Stedman,TimothyT;Wittum,Thomas;Wozniak,D
Antibacterial resistance continues its devastation of available therapies. Novel bacterial topoisomerase inhibitors (NBTIs) offer one solution to this critical issue. Two series of amine NBTIs bearing tricyclic DNA-binding moieties as well as amide NBTIs with a bicyclic DNA-binding moiety were synthesized and evaluated against methicillin-resistantStaphylococcus aureus(MRSA). Additionally, these compounds and a series of bicyclic amine analogues displayed high activity against susceptible and drug-resistantNeisseria gonorrhoeae, expanding the spectrum of these dioxane-linked NBTIs.